Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Biocept, Inc. - Common Stock
(NQ:
BIOC
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 24, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biocept, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Earnings Scheduled For August 16, 2021
↗
August 16, 2021
Companies Reporting Before The Bell • Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter. • Data Storage (NASDAQ:DTST) is expected to...
Via
Benzinga
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
↗
August 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Biocept Stock Drops Despite Clocking Q2 Sales Of $12M
↗
August 17, 2021
Biocept Inc (NASDAQ: BIOC) reported its second-quarter revenues of $12 million, compared to a mere $917,471 a year ago, but sharply missing the consensus of $17.76...
Via
Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
↗
August 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
August 17, 2021
Gainers Forte Biosciences (NASDAQ:FBRX) stock increased by 16.38% to $27.7 during Tuesday's pre-market session. The market value of their outstanding shares is at $374...
Via
Benzinga
Biocept Reports Second Quarter 2021 Financial Results
August 16, 2021
From
Biocept, Inc.
Via
Business Wire
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
↗
August 15, 2021
Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small-...
Via
Benzinga
Topics
Initial Public Offering
Biocept to Report Second Quarter 2021 Financial Results and Host Investor Conference Call on August 16, 2021
August 09, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept Names David Karlander as Senior Vice President of Commercial Operations
August 03, 2021
From
Biocept
Via
Business Wire
Medicare Issues Local Coverage Determination for Biocept’s Target Selector™ Breast Cancer Assay to Detect the HER2 Biomarker from Circulating Tumor Cells
July 21, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept Welcomes Linda Rubinstein and Antonino Morales to Board of Directors, Names Director Samuel Riccitelli as Chairman
July 20, 2021
From
Biocept, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
July 19, 2021
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO
Via
Benzinga
Biocept to Participate in Two July Investment Conferences
July 19, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept Receives South Korean Patent for Primer-Switch Platform Used to Identify Rare Genetic Mutations, Including Cancer Biomarkers
July 06, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept Joins the Russell Microcap® Index
June 28, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept Stock Moves Higher On Collaboration With Quest Diagnostics For Liquid Biopsy Testing For Lung Cancer Patients
↗
June 22, 2021
Biocept Inc (NASDAQ: BIOC) has collaborated with Quest Diagnostics Inc (NYSE: DGX) to provide laboratory testing services to Quest patients for its Target...
Via
Benzinga
Biocept to Collaborate with Quest Diagnostics to Provide Advanced NGS-Based Liquid Biopsy Testing for Patients with Lung Cancer
June 22, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept Receives More Than 420,000 Samples During First Year of Offering COVID-19 Testing Service
June 15, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept and CLEARED4 Collaborate to Develop New Service for Managing COVID-19 Testing and Results Reporting for Biocept Customers
June 09, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept to Present at the LD Micro Virtual Invitational XI Conference on June 9, 2021
June 03, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 02, 2021
From
Biocept, Inc.
Via
Business Wire
MedTech Round Up: Update On Johnson & Johnson, Becton Dickinson, Labcorp, Second Sight Medical, Biocept
↗
May 13, 2021
Johnson & Johnson's (NYSE: JNJ) Vision segment has won FDA approval for the first contact lenses designed to reshape the cornea curve and help treat...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
May 13, 2021
Gainers Palisade Bio (NASDAQ:PALI) shares moved upwards by 35.23% to $7.1 during Thursday's pre-market session. Lianluo Smart (NASDAQ:LLIT) shares rose 19.37% to $7.21...
Via
Benzinga
Biocept Reports First Quarter 2021 Financial Results
May 12, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept to Report First Quarter 2021 Financial Results and Host Investor Conference Call on May 12, 2021
May 05, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept to Supply COVID-19 Testing Through Partnership With the Foundation for California Community Colleges
April 28, 2021
From
Biocept, Inc.
Via
Business Wire
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
↗
May 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...
Via
Benzinga
Earnings Scheduled For May 12, 2021
↗
May 12, 2021
Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter. • Boyd Gaming (NYSE:BYD) is projected to report...
Via
Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
↗
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
Biocept Announces Full Commercial Launch of CNSide™ Cerebrospinal Fluid Assay to Address Unmet Needs for Patients with Metastatic Brain Cancer
April 21, 2021
From
Biocept, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
